Skip to content

Drug interactions

Azelastine + Lomitapide

Severity: Moderate

Azelastine and Lomitapide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lomitapide is extensively metabolized by CYP3A4 and its exposure rises with inhibitors, increasing the risk of hepatotoxicity and gastrointestinal effects. Azelastine is at most a weak inhibitor, but caution is warranted given lomitapide's narrow margin.

What this interaction means in plain words

Azelastine and Lomitapide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Azelastine belongs to Respiratory; Lomitapide belongs to Cardiovascular.

Evidence level: Low

Why it happens

Possible weak CYP3A4 inhibition reducing lomitapide clearance.

What to do

Monitor liver enzymes per the lomitapide monitoring schedule and keep the dose within labeled limits for weak inhibitors. Review the need for azelastine.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Azelastine and Lomitapide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Azelastine with Lomitapide?

MediHelp rates the interaction as moderate. Azelastine and Lomitapide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Lomitapide is extensively metabolized by CYP3A4 and its exposure rises with inhibitors, increasing the risk of hepatotoxicity and gastrointestinal effects. Azelastine is at most a weak inhibitor, but caution is warranted given lomitapide's narrow margin.

How serious is the interaction between Azelastine and Lomitapide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor liver enzymes per the lomitapide monitoring schedule and keep the dose within labeled limits for weak inhibitors. Review the need for azelastine.

What other medicines interact with Azelastine?

MediHelp also lists interactions of Azelastine with, for example, Calcium / magnesium / potassium / sodium oxybates, Methadone, Sodium oxybate. The full list is on the Azelastine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in